DOCS as reported
Doximity, Inc. reported $645M of revenue over the trailing twelve months, +13% on the year before. 10 reported series are charted on this page, each one as filed.
$645M
Revenue, trailing twelve months · to Q4 2026 · +13% against the twelve months before
- Net Income
- $196M
Net Income · −12% year on year · trailing twelve months to Q4 2026
- Op Margin
- 33%
Op Margin · trailing twelve months to Q4 2026
- EPS
- $0.99
EPS · −11% year on year · trailing twelve months to Q4 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $645M | +13% | Q4 2026 |
| Net Income | $196M | −12% | Q4 2026 |
| EPS | $0.99 | −11% | Q4 2026 |
| Gross Margin | 89% | n/a | Q4 2026 |
| Op Margin | 33% | n/a | Q4 2026 |
| Net Margin | 30% | n/a | Q4 2026 |
| ROE | 23% | n/a | Q4 2026 |
| ROA | 19% | n/a | Q4 2026 |
| Free Cash Flow | $273M | n/a | Q4 2025 · 4 quarters behind |
| P/E | 25.0 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Doximity, Inc. (DOCS) - Revenue & ProfitRevenue & ProfitDoximity, Inc. (DOCS)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Health Information Services
Ranks #8 of 14 by Smart Score